Expert solutions for oral and parenteral product development
based on proprietary nanotechnology
We are a specialised product development company dedicated to developing a pipeline of enhanced versions of existing drug products, and providing services to enable pre-clinical and clinical stage formulations for our clients NCEs or branded established drugs.
leon-nanodrugs offers access to the next generation of nano-formulated drugs with meaningful differentiation and added patient benefits.
We specialize in improving the bioavailability of poorly water soluble drugs by using leon’s proprietary MJR® Technology platform to create either polymeric or crystalline nanoparticles.
leons meaningful differentiation…
- Improved bioavailability, Faster onset of action, Dose reduction resulting in lower drug exposure, Improved stability
- Extension of life cycle, Earlier to market
- Lower pill burden, eliminate food effect, increased patient compliance
- 3 year goal from concept to FDA / EMA, submission due to abbreviated regulatory pathway, e.g. 505(b)2, Hybrid Application